Gallium Citrate Ga 67

CHEMBL1200994 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
256.0 g/mol
LogP
Phase
4

A salt form of gallium citrate, sharing the same therapeutic uses.

Moleküler Ağırlık

256,0300 g/mol

TPSA

141,00 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[67Ga+3]

InChI

InChI=1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3/i;1-3

Molecular Formula

C6H5GaO7

HBD / HBA

1 / 7

Döndürülebilir Bağlar

2

Ağır Atomlar

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A salt form of gallium citrate, sharing the same therapeutic uses.

Yes, Gallium Citrate Ga 67 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200994. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65430. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.